Originally Posted by Bwana:
Once again, don't come in this thread with some kind of political agenda, or you will be shown the door. If you want to go that route, there is a thread about this in DC.
Originally Posted by Dartgod:
People, there is a lot of good information in this thread, let's try to keep the petty bickering to a minimum.
We all have varying opinions about the impact of this, the numbers, etc. We will all never agree with each other. But we can all keep it civil.
Thanks!
Click here for the original OP:
Spoiler!
Apparently the CoronaVirus can survive on a inanimate objects, such as door knobs, for 9 days.
California coronavirus case could be first spread within U.S. community, CDC says
By SOUMYA KARLAMANGLA, JACLYN COSGROVE
FEB. 26, 2020 8:04 PM
The Centers for Disease Control and Prevention is investigating what could be the first case of novel coronavirus in the United States involving a patient in California who neither recently traveled out of the country nor was in contact with someone who did.
“At this time, the patient’s exposure is unknown. It’s possible this could be an instance of community spread of COVID-19, which would be the first time this has happened in the United States,” the CDC said in a statement. “Community spread means spread of an illness for which the source of infection is unknown. It’s also possible, however, that the patient may have been exposed to a returned traveler who was infected.”
The individual is a resident of Solano County and is receiving medical care in Sacramento County, according to the state Department of Public Health.
The CDC said the “case was detected through the U.S. public health system — picked up by astute clinicians.”
Officials at UC Davis Medical Center expanded on what the federal agency might have meant by that in an email sent Wednesday, as reported by the Davis Enterprise newspaper.
The patient arrived at UC Davis Medical Center from another hospital Feb. 19 and “had already been intubated, was on a ventilator, and given droplet protection orders because of an undiagnosed and suspected viral condition,” according to an email sent by UC Davis officials that was obtained by the Davis Enterprise.
The staff at UC Davis requested COVID-19 testing by the CDC, but because the patient didn’t fit the CDC’s existing criteria for the virus, a test wasn’t immediately administered, according to the email. The CDC then ordered the test Sunday, and results were announced Wednesday. Hospital administrators reportedly said in the email that despite these issues, there has been minimal exposure at the hospital because of safety protocols they have in place.
A UC Davis Health spokesperson declined Wednesday evening to share the email with The Times.
Since Feb. 2, more than 8,400 returning travelers from China have entered California, according to the state health department. They have been advised to self-quarantine for 14 days and limit interactions with others as much as possible, officials said.
“This is a new virus, and while we are still learning about it, there is a lot we already know,” Dr. Sonia Angell, director of the California Department of Public Health, said in a statement. “We have been anticipating the potential for such a case in the U.S., and given our close familial, social and business relationships with China, it is not unexpected that the first case in the U.S. would be in California.”
It is not clear how the person became infected, but public health workers could not identify any contacts with people who had traveled to China or other areas where the virus is widespread. That raises concern that the virus is spreading in the United States, creating a challenge for public health officials, experts say.
“It’s the first signal that we could be having silent transmission in the community,” said Lawrence Gostin, director of the World Health Organization Collaborating Center on National and Global Health Law. “It probably means there are many more cases out there, and it probably means this individual has infected others, and now it’s a race to try to find out who that person has infected.”
On Tuesday, the CDC offered its most serious warning to date that the United States should expect and prepare for the coronavirus to become a more widespread health issue.
“Ultimately, we expect we will see coronavirus spread in this country,” said Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases. “It’s not so much a question of if, but a question of when.”
According to the CDC’s latest count Wednesday morning, 59 U.S. residents have tested positive for the new strain of coronavirus — 42 of whom are repatriated citizens from a Diamond Princess cruise. That number has grown by two since Messonnier’s last count Tuesday, although the CDC was not immediately available to offer details on the additional cases.
More than 82,000 cases of coronavirus have been reported globally, and more than 2,700 people have died, with the majority in mainland China, the epicenter of the outbreak.
But public health leaders have repeatedly reminded residents that the health risk from the novel coronavirus to the general public remains low.
“While COVID-19 has a high transmission rate, it has a low mortality rate,” the state Department of Public Health said in a statement Wednesday. “From the international data we have, of those who have tested positive for COVID-19, approximately 80% do not exhibit symptoms that would require hospitalization. There have been no confirmed deaths related to COVID-19 in the United States to date.”
CDC officials have also warned that although the virus is likely to spread in U.S. communities, the flu still poses a greater risk.
Gostin said the news of potential silent transmission does not eliminate the possibility of containing the virus in the U.S. and preventing an outbreak.
“There are few enough cases that we should at least try,” he said. “Most of us are not optimistic that that will be successful, but we’re still in the position to try.”
Originally Posted by Discuss Thrower:
So you just blast asymptomatic people who have been in close verifiable proximity to confirmed infected with the malaria meds?
No, don't think so.
Depending on efficacy of it you'd probably just have to wait and use in on symptomatic people.
Originally Posted by TLO:
My Mom is a pharmacist and is also very excited about these developments. She had talked to me about trials being done in other countries, but no news media here was giving it much attention.
This drug has been around since the 1950's I believe. It's cheap and fairly easy to make. There are possible side effects (as with any medication) - but that's a calculated risk we have to take.
Fire up the production line and get this shit out.
Nothing is going to be used in the US unless it can be monetized for significant profit. [Reply]
Originally Posted by dirk digler:
FDA is now saying don't expect this anytime soon. They will want to do a bunch of trials and that will take forever probably.
The FDA isn't going to put on the label "Coronavirus Cure and Prevention" anytime soon. But they seem willing to let patients use it as a treatment option (as long as they can collect data on it) [Reply]
Any other business owners feeling this shit yet? My bakery employs 18 people and I’m down 60% already. Going to bleed as long as possible but this hurts. [Reply]
Originally Posted by srvy:
He is a dick he has been warned plenty times here and he says I'm sorry and does it again. He is an overreacting bs spreading blowhard.
But other than that....he's a great guy!!!:-) [Reply]
Depending on efficacy of it you'd probably just have to wait and use in on symptomatic people.
That's a question for Hamas.
Unless it's proven to prevent healthcare workers from contacting the disease. (These are the types of studies that will take a long time to compile data from)
That's just my guess. I honestly don't know that. [Reply]
Originally Posted by TLO:
The FDA isn't going to put on the label "Coronavirus Cure and Prevention" anytime soon. But they seem willing to let patients use it as a treatment option (as long as they can collect data on it)
The biggest thing is that the drug is a known entity, so we know that it typically doesn't HARM people beyond relatively minor side effects. As you said, they'll take a while to say "it works," but it sounds like they'll let people try it out while they study it. [Reply]
Originally Posted by MIAdragon:
Any other business owners feeling this shit yet? My bakery employs 18 people and I’m down 60% already. Going to bleed as long as possible but this hurts.
Car sales opportunities are SIGNIFICANTLY down...thank God for CP! [Reply]
Originally Posted by DJ's left nut:
I wonder if that speaks primarily to wholesale implementation.
Hamas mentioned certain demographics don't respond well or suffer adverse side effects due to these cocktails (IIRC) and that would seem to suggest that maybe they're going to have to firm up data before they simply take their hands off the wheel and allow it to be used across the board.
Especially if, as I believe Hamas suggested, there are concerns over growing resistance and thus long-term declines in efficacy.
But it would seem that they could allow targeted applications fairly quickly. And public pressure will mount exponentially to do exactly that.
Originally Posted by BleedingRed:
Didn't this administration sign a bill for this type of thing "Right to Try". maybe provisions of that law could be used to go around the FDA
The side effects are seizures, nausea, vomiting, deafness, vision changes and low blood pressure.
I think they approved it for compassion cases which we all know what that means.
Originally Posted by :
FDA Commissioner Stephen Hahn carefully tempered the President's remarks regarding his team's work to develop treatments for coronavirus.
"The FDA is committed to continuing to provide regulatory flexibility and guidance, but let me make one thing clear: the FDA's responsibility to the American people is to ensure that products are safe and effective," he said.
He said the FDA is expanding its work regarding potential therapeutic options.
"We need to make sure that this sea of new treatments -- we'll get the right drug to the right patient at the right dosage at the right time," he said, explaining that the right drug may be available but it may not be in the right dosage, "and that may do more harm than good."
Part of that, Hahn said, is exploring drugs that are "already approved for other indications," noting the President's remarks on chloroquine.
"That's a drug that the President has directed us to take a closer look at as to whether an expanded use approach to that could be done and to actually see if that benefits patients. And again, we want to do that in the setting of a clinical trial, a large, pragmatic clinical trial to actually gather that information," he said.
He also explained the process of convalescent plasma, which has to do with isolating blood from those who have survived the coronavirus and have the right immunoglobulins. A concentration of that could treat people infected with the virus.
As for a timeline, Hahn said, "over the next couple of weeks, we'll have more information that we're really pushing hard to try to accelerate... and that will be a bridge to other therapies that will take us three to six months to develop. And this is a continuous process -- there is no beginning and end."
Originally Posted by MIAdragon:
Any other business owners feeling this shit yet? My bakery employs 18 people and I’m down 60% already. Going to bleed as long as possible but this hurts.
can you do take out or delivery to blunt the economic impact until this passes? [Reply]
